Bluestone and colleagues [52] have shown that transgenic B cells decorated with surface-linked agonistic CTLA-4 scFv antibodies are able to prevent NOD mice from developing T1D. The gene discussed is CTLA4; the disease is type 1 diabetes mellitus.